{"title":"将肿瘤免疫微环境作为肝细胞癌发展的新治疗靶点","authors":"Eunjeong Kim","doi":"10.12717/DR.2023.27.4.167","DOIUrl":null,"url":null,"abstract":"<p><p>Development of hepatocellular carcinoma (HCC) is driven by a multistep and long-term process. Because current therapeutic strategies are limited for HCC patients, there are increasing demands for understanding of immunotherapy, which has made technological and conceptual innovations in the treatment of cancer. Here, I discuss HCC immunotherapy in the view of interaction between liver resident cells and immune cells.</p>","PeriodicalId":72791,"journal":{"name":"Development & reproduction","volume":"27 4","pages":"167-174"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10824567/pdf/","citationCount":"0","resultStr":"{\"title\":\"Tumor Immune Microenvironment as a New Therapeutic Target for Hepatocellular Carcinoma Development.\",\"authors\":\"Eunjeong Kim\",\"doi\":\"10.12717/DR.2023.27.4.167\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Development of hepatocellular carcinoma (HCC) is driven by a multistep and long-term process. Because current therapeutic strategies are limited for HCC patients, there are increasing demands for understanding of immunotherapy, which has made technological and conceptual innovations in the treatment of cancer. Here, I discuss HCC immunotherapy in the view of interaction between liver resident cells and immune cells.</p>\",\"PeriodicalId\":72791,\"journal\":{\"name\":\"Development & reproduction\",\"volume\":\"27 4\",\"pages\":\"167-174\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10824567/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Development & reproduction\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12717/DR.2023.27.4.167\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/12/31 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Development & reproduction","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12717/DR.2023.27.4.167","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/31 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Tumor Immune Microenvironment as a New Therapeutic Target for Hepatocellular Carcinoma Development.
Development of hepatocellular carcinoma (HCC) is driven by a multistep and long-term process. Because current therapeutic strategies are limited for HCC patients, there are increasing demands for understanding of immunotherapy, which has made technological and conceptual innovations in the treatment of cancer. Here, I discuss HCC immunotherapy in the view of interaction between liver resident cells and immune cells.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
